{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T02:19:10Z","timestamp":1792549150698,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Pharmacol Sin"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1038\/s41401-026-01827-4","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T05:48:55Z","timestamp":1779860935000},"page":"2479-2492","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The solute carrier transporter SLCO5A1 as a novel therapeutic target for the treatment of myocardial infarction-induced heart failure"],"prefix":"10.1038","volume":"47","author":[{"given":"Ke-yu","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-rong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang-qing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5141-325X","authenticated-orcid":false,"given":"Wen-liang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"1827_CR1","doi-asserted-by":"publisher","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","volume":"118","author":"G Savarese","year":"2023","unstructured":"Savarese G, Becher PM, Lund LH, Seferovic P, Rosano GMC, Coats AJS. Global burden of heart failure: a comprehensive and updated review of epidemiology. Cardiovasc Res. 2023;118:3272\u201387.","journal-title":"Cardiovasc Res"},{"key":"1827_CR2","doi-asserted-by":"publisher","first-page":"e144","DOI":"10.1161\/CIRCRESAHA.125.326201","volume":"137","author":"H Li","year":"2025","unstructured":"Li H, Wang X, Zhang Y, Yang Y, Zhang JZ, Zhou B. SLC39A13 regulates heart function via mitochondrial iron homeostasis maintenance. Circ Res. 2025;137:e144\u2013e56.","journal-title":"Circ Res"},{"key":"1827_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2024.05.012","volume":"221","author":"D Yao","year":"2024","unstructured":"Yao D, Bao L, Wang S, Tan M, Xu Y, Wu T, et al. Isoliquiritigenin alleviates myocardial ischemia-reperfusion injury by regulating the Nrf2\/HO-1\/SLC7a11\/GPX4 axis in mice. Free Radic Biol Med. 2024;221:1\u201312.","journal-title":"Free Radic Biol Med"},{"key":"1827_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmr.2024.100023","volume":"77","author":"B Hagenbuch","year":"2025","unstructured":"Hagenbuch B, Stieger B, Locher KP. Organic anion transporting polypeptides: pharmacology, toxicology, structure, and transport mechanisms. Pharmacol Rev. 2025;77:100023.","journal-title":"Pharmacol Rev"},{"key":"1827_CR5","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","volume":"165","author":"M Roth","year":"2012","unstructured":"Roth M, Obaidat A, Hagenbuch B. OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies. Br J Pharmacol. 2012;165:1260\u201387.","journal-title":"Br J Pharmacol"},{"key":"1827_CR6","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.ajhg.2010.05.012","volume":"87","author":"B Isidor","year":"2010","unstructured":"Isidor B, Pichon O, Redon R, Day-Salvatore D, Hamel A, Siwicka KA, et al. Mesomelia-synostoses syndrome results from deletion of SULF1 and SLCO5A1 genes at 8q13. Am J Hum Genet. 2010;87:95\u2013100.","journal-title":"Am J Hum Genet"},{"key":"1827_CR7","doi-asserted-by":"publisher","first-page":"3081","DOI":"10.1158\/1535-7163.MCT-08-0539","volume":"7","author":"M Okabe","year":"2008","unstructured":"Okabe M, Szakacs G, Reimers MA, Suzuki T, Hall MD, Abe T, et al. Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters. Mol Cancer Ther. 2008;7:3081\u201391.","journal-title":"Mol Cancer Ther"},{"key":"1827_CR8","doi-asserted-by":"publisher","first-page":"e83257","DOI":"10.1371\/journal.pone.0083257","volume":"8","author":"K Sebastian","year":"2013","unstructured":"Sebastian K, Detro-Dassen S, Rinis N, Fahrenkamp D, Muller-Newen G, Merk HF, et al. Characterization of SLCO5A1\/OATP5A1, a solute carrier transport protein with non-classical function. PLoS One. 2013;8:e83257.","journal-title":"PLoS One"},{"key":"1827_CR9","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.tibs.2023.05.011","volume":"48","author":"A Schlessinger","year":"2023","unstructured":"Schlessinger A, Zatorski N, Hutchinson K, Colas C. Targeting SLC transporters: small molecules as modulators and therapeutic opportunities. Trends Biochem Sci. 2023;48:801\u201314.","journal-title":"Trends Biochem Sci"},{"key":"1827_CR10","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2021.606931","volume":"12","author":"H Yamakawa","year":"2021","unstructured":"Yamakawa H, Kato TS, Noh JY, Yuasa S, Kawamura A, Fukuda K, et al. Thyroid hormone plays an important role in cardiac function: from bench to bedside. Front Physiol. 2021;12:606931.","journal-title":"Front Physiol"},{"key":"1827_CR11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10741-008-9125-7","volume":"15","author":"W Dillmann","year":"2010","unstructured":"Dillmann W. Cardiac hypertrophy and thyroid hormone signaling. Heart Fail Rev. 2010;15:125\u201332.","journal-title":"Heart Fail Rev"},{"key":"1827_CR12","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.mce.2017.01.003","volume":"458","author":"G Rutigliano","year":"2017","unstructured":"Rutigliano G, Zucchi R. Cardiac actions of thyroid hormone metabolites. Mol Cell Endocrinol. 2017;458:76\u201381.","journal-title":"Mol Cell Endocrinol"},{"key":"1827_CR13","doi-asserted-by":"publisher","first-page":"5063","DOI":"10.1210\/en.2010-0491","volume":"151","author":"A Saba","year":"2010","unstructured":"Saba A, Chiellini G, Frascarelli S, Marchini M, Ghelardoni S, Raffaelli A, et al. Tissue distribution and cardiac metabolism of 3-iodothyronamine. Endocrinology. 2010;151:5063\u201373.","journal-title":"Endocrinology"},{"key":"1827_CR14","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s10557-011-6320-x","volume":"25","author":"S Frascarelli","year":"2011","unstructured":"Frascarelli S, Ghelardoni S, Chiellini G, Galli E, Ronca F, Scanlan TS, et al. Cardioprotective effect of 3-iodothyronamine in perfused rat heart subjected to ischemia and reperfusion. Cardiovasc Drugs Ther. 2011;25:307\u201313.","journal-title":"Cardiovasc Drugs Ther"},{"key":"1827_CR15","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1111\/j.1476-5381.2012.01958.x","volume":"166","author":"S Cumero","year":"2012","unstructured":"Cumero S, Fogolari F, Domenis R, Zucchi R, Mavelli I, Contessi S. Mitochondrial F0F1 -ATP synthase is a molecular target of 3-iodothyronamine, an endogenous metabolite of thyroid hormone. Br J Pharmacol. 2012;166:2331\u201347.","journal-title":"Br J Pharmacol"},{"key":"1827_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/biostatistics\/kxj037","volume":"8","author":"WE Johnson","year":"2007","unstructured":"Johnson WE, Li C, Rabinovic A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics. 2007;8:118\u201327.","journal-title":"Biostatistics"},{"key":"1827_CR17","first-page":"20150202","volume":"374","author":"IT Jolliffe","year":"2016","unstructured":"Jolliffe IT, Cadima J. Principal component analysis: a review and recent developments. Philos Trans A Math Phys Eng Sci. 2016;374:20150202.","journal-title":"Philos Trans A Math Phys Eng Sci"},{"key":"1827_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.85","volume":"2","author":"F Lyu","year":"2023","unstructured":"Lyu F, Han F, Ge C, Mao W, Chen L, Hu H, et al. OmicStudio: A composable bioinformatics cloud platform with real-time feedback that can generate high-quality graphs for publication. Imeta. 2023;2:e85.","journal-title":"Imeta"},{"key":"1827_CR19","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/s41588-021-00978-w","volume":"53","author":"E Ferkingstad","year":"2021","unstructured":"Ferkingstad E, Sulem P, Atlason BA, Sveinbjornsson G, Magnusson MI, Styrmisdottir EL, et al. Large-scale integration of the plasma proteome with genetics and disease. Nat Genet. 2021;53:1712\u201321.","journal-title":"Nat Genet"},{"key":"1827_CR20","doi-asserted-by":"publisher","first-page":"277","DOI":"10.26599\/1671-5411.2025.03.002","volume":"22","author":"SY Zhang","year":"2025","unstructured":"Zhang SY. Chinese guidelines for the diagnosis and treatment of heart failure 2024. J Geriatr Cardiol. 2025;22:277\u2013331.","journal-title":"J Geriatr Cardiol"},{"key":"1827_CR21","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1038\/s41420-023-01457-3","volume":"9","author":"S Li","year":"2023","unstructured":"Li S, Shen S, Xu H, Cai S, Yuan X, Wang C, et al. IGF2BP3 promotes adult myocardial regeneration by stabilizing MMP3 mRNA through interaction with m6A modification. Cell Death Discov. 2023;9:164.","journal-title":"Cell Death Discov"},{"key":"1827_CR22","doi-asserted-by":"publisher","first-page":"168","DOI":"10.21037\/atm-21-7041","volume":"10","author":"H Zhou","year":"2022","unstructured":"Zhou H, Mo L, Huang N, Zou C, Li C, Lin M, et al. 3-Iodothyronamine inhibits apoptosis induced by myocardial ischemia reperfusion via the Akt\/FoxO1 signaling pathway. Ann Transl Med. 2022;10:168.","journal-title":"Ann Transl Med"},{"key":"1827_CR23","volume":"26","author":"H Zhou","year":"2020","unstructured":"Zhou H, Hu B, Liu X. Thyroid hormone metabolite 3-iodothyronamine (T1AM) alleviates hypoxia\/reoxygenation-induced cardiac myocyte apoptosis via Akt\/FoxO1 pathway. Med Sci Monit. 2020;26:e923195.","journal-title":"Med Sci Monit"},{"key":"1827_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4833791","volume":"2022","author":"B Wei","year":"2022","unstructured":"Wei B, Zhao H, Hu B, Dai L, Zhang G, Mo L, et al. T1AM attenuates the hypoxia\/reoxygenation-induced necroptosis of H9C2 cardiomyocytes via RIPK1\/RIPK3 pathway. Biomed Res Int. 2022;2022:4833791.","journal-title":"Biomed Res Int"},{"key":"1827_CR25","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1161\/CIRCULATIONAHA.118.038361","volume":"139","author":"S Huang","year":"2019","unstructured":"Huang S, Li X, Zheng H, Si X, Li B, Wei G, et al. Loss of super-enhancer-regulated circRNA Nfix induces cardiac regeneration after myocardial infarction in adult mice. Circulation. 2019;139:2857\u201376.","journal-title":"Circulation"},{"key":"1827_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s00395-023-01026-w","volume":"119","author":"M Zheng","year":"2024","unstructured":"Zheng M, Chen S, Zeng Z, Cai H, Zhang H, Yu X, et al. Targeted ablation of the left middle cervical ganglion prevents ventricular arrhythmias and cardiac injury induced by AMI. Basic Res Cardiol. 2024;119:57\u201374.","journal-title":"Basic Res Cardiol"},{"key":"1827_CR27","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","volume":"113","author":"A Lymperopoulos","year":"2013","unstructured":"Lymperopoulos A, Rengo G, Koch WJ. Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res. 2013;113:739\u201353.","journal-title":"Circ Res"},{"key":"1827_CR28","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1161\/CIRCULATIONAHA.121.055727","volume":"145","author":"L Zhuang","year":"2022","unstructured":"Zhuang L, Jia K, Chen C, Li Z, Zhao J, Hu J, et al. DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics. Circulation. 2022;145:829\u201346.","journal-title":"Circulation"},{"key":"1827_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-018-0598-6","volume":"9","author":"L Weng","year":"2018","unstructured":"Weng L, Jia S, Xu C, Ye J, Cao Y, Liu Y, et al. Nogo-C regulates post myocardial infarction fibrosis through the interaction with ER Ca2+ leakage channel Sec61alpha in mouse hearts. Cell Death Dis. 2018;9:612.","journal-title":"Cell Death Dis"},{"key":"1827_CR30","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1056\/NEJM199507133330201","volume":"333","author":"SN Singh","year":"1995","unstructured":"Singh SN, Fletcher RD, Fisher SG, Singh BN, Lewis HD, Deedwania PC, et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival trial of antiarrhythmic therapy in congestive heart failure. N Engl J Med. 1995;333:77\u201382.","journal-title":"N Engl J Med"},{"key":"1827_CR31","doi-asserted-by":"crossref","unstructured":"Gudjonsson P, Andersen K, Einarsson H, Ingimarsdottir IJ. Survival impact of amiodarone therapy in heart failure: insights from the Icelandic heart failure registry. Eur Heart J. 2025;46:ehaf784-1285.","DOI":"10.1093\/eurheartj\/ehaf784.1285"},{"key":"1827_CR32","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1080\/14728222.2024.2316735","volume":"28","author":"NG Frangogiannis","year":"2024","unstructured":"Frangogiannis NG. TGF-beta as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities. Expert Opin Ther Targets. 2024;28:45\u201356.","journal-title":"Expert Opin Ther Targets"},{"key":"1827_CR33","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.mam.2012.10.009","volume":"34","author":"B Hagenbuch","year":"2013","unstructured":"Hagenbuch B, Stieger B. The SLCO (former SLC21) superfamily of transporters. Mol Aspects Med. 2013;34:396\u2013412.","journal-title":"Mol Aspects Med"},{"key":"1827_CR34","doi-asserted-by":"crossref","unstructured":"Richmond RC, Davey Smith G. Mendelian randomization: concepts and scope. Cold Spring Harb Perspect Med. 2022;12:a040501.","DOI":"10.1101\/cshperspect.a040501"},{"key":"1827_CR35","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1039\/B926583J","volume":"6","author":"AG Ianculescu","year":"2010","unstructured":"Ianculescu AG, Scanlan TS. 3-Iodothyronamine (T(1)AM): a new chapter of thyroid hormone endocrinology?. Mol Biosyst. 2010;6:1338\u201344.","journal-title":"Mol Biosyst"},{"key":"1827_CR36","doi-asserted-by":"publisher","first-page":"E69","DOI":"10.1210\/jc.2011-1115","volume":"97","author":"E Galli","year":"2012","unstructured":"Galli E, Marchini M, Saba A, Berti S, Tonacchera M, Vitti P, et al. Detection of 3-iodothyronamine in human patients: a preliminary study. J Clin Endocrinol Metab. 2012;97:E69\u201374.","journal-title":"J Clin Endocrinol Metab"},{"key":"1827_CR37","doi-asserted-by":"publisher","first-page":"226","DOI":"10.4330\/wjc.v16.i5.226","volume":"16","author":"V Culic","year":"2024","unstructured":"Culic V. Cardiovascular mechanisms of thyroid hormones and heart failure: current knowledge and perspectives. World J Cardiol. 2024;16:226\u201330.","journal-title":"World J Cardiol"},{"key":"1827_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.121575","volume":"321","author":"G Nicolini","year":"2023","unstructured":"Nicolini G, Balzan S, Forini F. Activated fibroblasts in cardiac and cancer fibrosis: an overview of analogies and new potential therapeutic options. Life Sci. 2023;321:121575.","journal-title":"Life Sci"},{"key":"1827_CR39","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41401-022-00963-x","volume":"44","author":"XL Dong","year":"2023","unstructured":"Dong XL, Yuan BH, Yu SZ, Liu H, Pan XH, Sun J, et al. Adriamycin induces cardiac fibrosis in mice via PRMT5-mediated cardiac fibroblast activation. Acta Pharmacol Sin. 2023;44:573\u201383.","journal-title":"Acta Pharmacol Sin"},{"key":"1827_CR40","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1038\/s41401-025-01488-9","volume":"46","author":"L Sun","year":"2025","unstructured":"Sun L, Zhang HB, Jiang HC, Li W, Li MK, Yang XY, et al. LMO7 drives profibrotic fibroblast polarization and pulmonary fibrosis in mice through TGF-beta signalling. Acta Pharmacol Sin. 2025;46:1930\u201345.","journal-title":"Acta Pharmacol Sin"},{"key":"1827_CR41","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s41401-024-01413-6","volume":"46","author":"ZJ Chia","year":"2025","unstructured":"Chia ZJ, Kumarapperuma H, Zhang R, Little PJ, Kamato D. Smad transcription factors as mediators of 7 transmembrane G protein-coupled receptor signalling. Acta Pharmacol Sin. 2025;46:795\u2013804.","journal-title":"Acta Pharmacol Sin"},{"key":"1827_CR42","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1093\/cvr\/cvu264","volume":"105","author":"JE Cartledge","year":"2015","unstructured":"Cartledge JE, Kane C, Dias P, Tesfom M, Clarke L, McKee B, et al. Functional crosstalk between cardiac fibroblasts and adult cardiomyocytes by soluble mediators. Cardiovasc Res. 2015;105:260\u201370.","journal-title":"Cardiovasc Res"},{"key":"1827_CR43","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/cvr\/cvad104","volume":"119","author":"X Chen","year":"2023","unstructured":"Chen X, Li X, Wu X, Ding Y, Li Y, Zhou G, et al. Integrin beta-like 1 mediates fibroblast-cardiomyocyte crosstalk to promote cardiac fibrosis and hypertrophy. Cardiovasc Res. 2023;119:1928\u201341.","journal-title":"Cardiovasc Res"},{"key":"1827_CR44","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1038\/s41401-024-01235-6","volume":"45","author":"ZJ Chia","year":"2024","unstructured":"Chia ZJ, Cao YN, Little PJ, Kamato D. Transforming growth factor-beta receptors: versatile mechanisms of ligand activation. Acta Pharmacol Sin. 2024;45:1337\u201348.","journal-title":"Acta Pharmacol Sin"},{"key":"1827_CR45","doi-asserted-by":"publisher","first-page":"10618","DOI":"10.1074\/jbc.270.18.10618","volume":"270","author":"CM Dubois","year":"1995","unstructured":"Dubois CM, Laprise MH, Blanchette F, Gentry LE, Leduc R. Processing of transforming growth factor beta 1 precursor by human furin convertase. J Biol Chem. 1995;270:10618\u201324.","journal-title":"J Biol Chem"}],"container-title":["Acta Pharmacologica Sinica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01827-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01827-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01827-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T08:04:47Z","timestamp":1787040287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41401-026-01827-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,27]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["1827"],"URL":"https:\/\/doi.org\/10.1038\/s41401-026-01827-4","relation":{},"ISSN":["1671-4083","1745-7254"],"issn-type":[{"value":"1671-4083","type":"print"},{"value":"1745-7254","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,27]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}